longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Trade
  • PortAI
Home
Discover
News & Info
Trade
PortAI
Overview
Details
Chat
Danaher Corporation's (DHR.US) Q1 2022 Earnings Call
Live streaming time: 21/04/2022 16:28
Danaher Corporation is a medical company that designs, manufactures, and markets professional medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic components of life, including genes, proteins, metabolites, and cells, to understand the causes of diseases, identify new treatments, and test new drugs and vaccines. The Diagnostics segment consists of analytical instruments, reagents, consumables, software, and services that hospitals, doctor's offices, reference laboratories, and other critical care institutions use to diagnose diseases and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect critical resources and ensure the safety of global food and water supplies. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, D.C.
Live Assistant
Risk and Disclaimer Statement:
The content on this page reflects the personal opinion of the author and is intended solely as general information for your reference. It shall not be construed as advice or a basis for any specific investment, business, or commercial decisions. The views expressed in the content do not represent any position of Longbridge or any investment recommendations or endorsements related to LongPort. Longbridge does not make any guarantee or commitment to the truthfulness, accuracy, or originality of the content. Investors should analyze the risks related to the investment based on their own circumstances and seek advice from a professional investment advisor when necessary.
© 2026 Longbridge|Disclaimer